SPONSOR
Hangzhou Qihan Biotech Co., Ltd.
Total Trials
1
Recruiting
1
Phases
Phase 1
Conditions studied: Systemic Lupus Erythematosus (SLE)
Hangzhou Qihan Biotech Co., Ltd. is a clinical research sponsor with 1 registered studies on ClinicalTrials.gov, of which 1 are actively recruiting participants. Research covers conditions including Systemic Lupus Erythematosus (SLE).
The trial portfolio spans Phase 1 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Hangzhou Qihan Biotech Co., Ltd.
How many clinical trials has Hangzhou Qihan Biotech Co., Ltd. sponsored?
ClinicalMetric currently tracks 1 clinical trials sponsored by Hangzhou Qihan Biotech Co., Ltd., of which 1 are actively recruiting participants. These trials cover conditions including Systemic Lupus Erythematosus (SLE). Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Hangzhou Qihan Biotech Co., Ltd. research focus on?
Hangzhou Qihan Biotech Co., Ltd. clinical trials span Systemic Lupus Erythematosus (SLE). The research pipeline includes Phase 1 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Hangzhou Qihan Biotech Co., Ltd. clinical trial?
To participate in a Hangzhou Qihan Biotech Co., Ltd. trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Hangzhou Qihan Biotech Co., Ltd. trials with current recruitment status updated daily.
Clinical Trials by Hangzhou Qihan Biotech Co., Ltd.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology